A Phase II Study of Oxaliplatin and Capecitabine (XELOX) in Patients with Unresectable Cholangiocarcinoma, including Carcinoma of the Gallbladder and Biliary Tract. - Glover,K.Y.; Thomas,M.B.; Brown,T.D. (Proc ASCO, 2005)